The US FDA has granted approval for AstraZeneca's FluMist, a needle-free nasal spray influenza vaccine for ...

AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...

US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science- ...

In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration.

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...

The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...

The FDA approved FluMist, a nasal spray flu vaccine for self-administration, making it the first flu vaccine of its kind available for at home use.

I love being able to go to the pharmacy for my own (or my kids’) flu shots. Pop in, get the shot, then go about my day. That ...

A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...

The FDA approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

James Gordon has given his Buy rating due to a combination of factors surrounding AstraZeneca’s position in the market and the assessment of their drug development pipeline. Firstly, despite the final ...

The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...